Is Removal of the Primary Tumor Beneficial in Breast Cancer with Synchronous Metastases? – There May Be More than One Answer

Publisher： Karger

E-ISSN： 2296-5262|34|11|581-582

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.11, 2011-10, pp. : 581-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast Cancer

Visceral Medicine: gastrointestinal medicine and surgery, Vol. 31, Iss. 6, 2015-0 ,pp. : 424-432

Karger

Access to resources Recommend Favorite

Is the Proportion of Patients Diagnosed with Synchronous Stage IV Breast Cancer Who Survive More than Two Years Increasing over Time?

Oncology, Vol. 89, Iss. 2, 2015-04 ,pp. : 79-87

Karger

Access to resources Recommend Favorite

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer

CANCER, Vol. 120, Iss. 9, 2014-05 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1617-1619

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Concordance Between Primary Breast Cancer and Matched Metastases

THE BREAST JOURNAL, Vol. 22, Iss. 4, 2016-07 ,pp. : 420-430

John Wiley & Sons Inc

Access to resources Recommend Favorite